ResMed target price raised to $250 from $215
RMD•Wells Fargo raised its target price for ResMed to $250 from $215.
Related News
ZEO Scientifix agrees to issue 41% stake to Pluri in licensing deal
PLUR•
Zone Frontier completes sale of legacy CleanCore cleaning products business
ZONE•
Big Oil's spending caution speaks louder than its profits: Bousso
XOM•
Verra Mobility announces third-quarter 2026 financial results
VRRM•
State Street launches SPYMX mutual fund share class of S&P 500 ETF
STT•